Shanghai Serum Bio-Technology Co., Ltd. (SHA:688163)
China flag China · Delayed Price · Currency is CNY
39.98
+0.89 (2.28%)
At close: May 12, 2026

SHA:688163 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
197.68196.21194.92190.13174.21207.5
Other Revenue
---0.020.011.19
197.68196.21194.92190.14174.22208.69
Revenue Growth (YoY)
1.77%0.66%2.51%9.14%-16.52%12.46%
Cost of Revenue
43.8942.9345.849.8433.536.33
Gross Profit
153.79153.28149.11140.3140.72172.36
Selling, General & Admin
79.0577.4676.7174.3573.7162.81
Research & Development
21.1319.5123.8430.4115.4625.76
Other Operating Expenses
1.391.451.681.531.211.45
Operating Expenses
101.5798.42102.96107.0890.2890.34
Operating Income
52.2254.8646.1533.2250.4582.03
Interest Expense
---0.43-0.65-0.68-0.71
Interest & Investment Income
9.099.186.1210.6216.31.48
Currency Exchange Gain (Loss)
---0.030.120.49-0.12
Other Non Operating Income (Expenses)
0.330.760.23-0.250.42-0.3
EBT Excluding Unusual Items
61.6464.7952.0443.0666.9782.38
Gain (Loss) on Sale of Investments
1.361.41-4.972.592.62-0.79
Gain (Loss) on Sale of Assets
-0.240.080.41-0.01-0.07-0.25
Asset Writedown
-2.29-2.08----
Other Unusual Items
--3.09-0.234.536.54
Pretax Income
60.4664.2150.5745.4274.0487.88
Income Tax Expense
11.8612.426.286.649.8411.39
Earnings From Continuing Operations
48.651.7944.2938.7764.276.48
Net Income
48.651.7944.2938.7764.276.48
Net Income to Common
48.651.7944.2938.7764.276.48
Net Income Growth
4.35%16.93%14.23%-39.60%-16.06%21.07%
Shares Outstanding (Basic)
9110810810810281
Shares Outstanding (Diluted)
9110810810810281
Shares Change (YoY)
-11.43%-0.13%0.30%5.70%25.24%0.46%
EPS (Basic)
0.540.480.410.360.630.94
EPS (Diluted)
0.540.480.410.360.630.94
EPS Growth
17.81%17.07%13.89%-42.86%-32.98%20.51%
Free Cash Flow
-8.830.93-9.124.1541.4664.68
Free Cash Flow Per Share
-0.100.01-0.080.040.410.80
Dividend Per Share
--0.3200.2000.7500.900
Dividend Growth
--60.00%-73.33%-16.67%-
Gross Margin
77.80%78.12%76.50%73.79%80.77%82.59%
Operating Margin
26.42%27.96%23.68%17.47%28.96%39.30%
Profit Margin
24.58%26.39%22.72%20.39%36.85%36.65%
Free Cash Flow Margin
-4.46%0.47%-4.68%2.18%23.79%30.99%
EBITDA
70.8373.6165.549.4664.4396.15
EBITDA Margin
35.83%37.52%33.61%26.01%36.98%46.07%
D&A For EBITDA
18.6118.7619.3616.2413.9814.12
EBIT
52.2254.8646.1533.2250.4582.03
EBIT Margin
26.42%27.96%23.68%17.47%28.96%39.30%
Effective Tax Rate
19.62%19.34%12.41%14.62%13.29%12.97%
Revenue as Reported
--194.92190.14174.22208.69
Source: S&P Global Market Intelligence. Standard template. Financial Sources.